STELLA PHARMA CORPORATION
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
4888 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区高麗橋三丁目２番７号 ＯＲＩＸ高麗橋ビル
- Website:
- https://stella-pharma.co.jp/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Stella Pharma Corporation is a pharmaceutical company engaged in the research, development, manufacturing, and sales of innovative drugs. The company specializes in Boron Neutron Capture Therapy (BNCT), a targeted radiation treatment for cancer. Its primary focus is on the development of boron compounds, including its approved drug Steboronine®, which is administered to patients prior to neutron irradiation. This therapy is primarily used for treating unresectable, locally advanced, or recurrent head and neck cancer. Stella Pharma aims to contribute to global healthcare by advancing BNCT as a new standard of care for various types of cancer.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for STELLA PHARMA CORPORATION and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-26 07:06 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | ||
| 2025-06-26 07:05 |
Annual Report
有価証券報告書－第18期(2024/04/01－2025/03/31)
|
Japanese | 1.2 MB | ||
| 2025-06-26 07:05 |
Regulatory News Service
内部統制報告書－第18期(2024/04/01－2025/03/31)
|
Japanese | 21.7 KB | ||
| 2025-06-25 06:52 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 21.4 KB | ||
| 2024-11-12 05:07 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB | ||
| 2024-11-12 05:06 |
Interim Report
半期報告書－第18期(2024/04/01－2025/03/31)
|
Japanese | 192.3 KB | ||
| 2024-07-01 02:34 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 28.0 KB | ||
| 2024-06-28 07:05 |
Governance Information
内部統制報告書－第17期(2023/04/01－2024/03/31)
|
Japanese | 21.3 KB | ||
| 2024-06-28 07:04 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2024-06-28 07:04 |
Annual Report
有価証券報告書－第17期(2023/04/01－2024/03/31)
|
Japanese | 1.1 MB | ||
| 2024-02-14 05:13 |
Quarterly Report
四半期報告書－第17期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 145.0 KB | ||
| 2024-02-14 05:13 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | ||
| 2023-11-14 06:08 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB | ||
| 2023-11-14 06:07 |
Quarterly Report
四半期報告書－第17期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 172.5 KB | ||
| 2023-08-10 06:38 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB |
Automate Your Workflow. Get a real-time feed of all STELLA PHARMA CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for STELLA PHARMA CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
